Force Inspiration
Angel Round in 2025
Force Inspiration is a start-up focusing on embodied intelligence technology. The company mainly engages in technology development, technical consulting, software development, basic artificial intelligence software development, information system integration services, intelligent robot research and development and sales, and industrial robot manufacturing and sales.
Pulnovo Medical
Series C in 2025
Pulnovo Medical, established in 2013 in Wuxi, Anhui, is focused on the development, production, and service provision of innovative medical technologies. The company specializes in creating advanced equipment for treating pulmonary hypertension, particularly through the use of pulse radiofrequency ablation technology. Its core products include pioneering high-frequency ablation equipment and intravascular catheters, which are protected by global invention patents. Pulnovo Medical aims to enhance the quality of life for patients suffering from pulmonary hypertension and heart failure by offering cutting-edge treatment solutions.
DH-Robotics
Venture Round in 2025
DH Robotics Technology Co., Ltd., founded in 2016 and based in China, specializes in the research and development of robotic hands and industrial robots. The company focuses on creating electric gripping jaws intended to enhance intelligent manufacturing processes. Its products are designed to be stable, secure, and easily integrated, catering to the needs of advanced manufacturing and lean production. By developing cost-effective solutions, DH Robotics aims to support flexible and intelligent demands within the manufacturing sector.
Makera
Angel Round in 2025
Makera is essentially creating a maker's dream CNC machine; we use it every day for various projects and enjoy the experience, and we hope you will too.
Xinzeyuan
Series B in 2025
Xinzeyuan Medical specializes in the manufacturing of critical precision components and disposable medical endoscopes, serving primarily hospital clients. Their product portfolio includes minimally invasive surgical instruments and other medical consumables, aiming to enhance safety and efficiency in surgical procedures for healthcare professionals.
Dearer Medical
Venture Round in 2024
Dearer Medical is a medical device company based in China that specializes in the development, production, and sales of eye-related products, particularly contact lenses. The company is dedicated to research and development in this field, focusing on both practical and fashionable color contact lens options. By combining innovation with quality manufacturing, Dearer Medical aims to meet the diverse needs of customers seeking enhanced vision solutions.
Original Point
Series C in 2024
Original Point focuses on the development of CNC systems with five-axis and multi-axis linkage capabilities.
Xinzeyuan
Series B in 2024
Xinzeyuan Medical specializes in the manufacturing of critical precision components and disposable medical endoscopes, serving primarily hospital clients. Their product portfolio includes minimally invasive surgical instruments and other medical consumables, aiming to enhance safety and efficiency in surgical procedures for healthcare professionals.
DK Medtech
Series E in 2024
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.
Horizone Technologies
Series A in 2024
Horizone Technologies is membrane materials and excellent filtration solutions manufacturer focusing on the R&D and production
DH-Robotics
Series C in 2024
DH Robotics Technology Co., Ltd., founded in 2016 and based in China, specializes in the research and development of robotic hands and industrial robots. The company focuses on creating electric gripping jaws intended to enhance intelligent manufacturing processes. Its products are designed to be stable, secure, and easily integrated, catering to the needs of advanced manufacturing and lean production. By developing cost-effective solutions, DH Robotics aims to support flexible and intelligent demands within the manufacturing sector.
PRCXI Biotechnology
Seed Round in 2024
PRCXI Biotechnology is a biotech company that provides bioinformatics and automation solutions for life science and the manufacturing of analytical instruments.
Sano Dynamics
Series A in 2023
Sano Dynamics is a producer of hydraulic system core components and hydraulic industrial robots.
Lixin Huigan
Series A in 2023
Lixin Huigan is a full-service manufacturer of sensors and an application service provider with an emphasis on the creation of premium micro-nanosensors.
iNexBot is a developer and manufacturer specializing in robot motion controllers and industrial robot intelligence technology. The company focuses on the research and development of advanced solutions for various sectors, including industrial robotics, collaborative robotics, semiconductors, healthcare automation, and automotive electronics. iNexBot provides essential hardware and software components, including control systems, robot cabinets, and fieldbus IO, to support robot manufacturers in enhancing their robotic products. Additionally, the company is involved in developing machine vision technology and laser seam tracking technology, further expanding its offerings in the robotics field.
Saints & Sages
Series B in 2023
Saints & Sages Medical specializes in the development and production of minimally invasive surgical medical devices. The company offers a range of energy devices that are utilized across various medical fields, including hepatobiliary, gynecology, urology, thoracic surgery, thyroid and breast surgery, and gastrointestinal surgery. With a commitment to addressing clinical needs, Saints & Sages focuses on innovation in surgical technology. They leverage a dedicated research and development team and extensive clinical experience to create devices that enhance the precision and efficiency of surgical procedures, ultimately aiming to improve patient outcomes globally.
DK Medtech
Venture Round in 2023
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.
Ricoton is a medical device company based in Hunan, China, specializing in the development and production of devices for cerebrovascular diseases. Founded in 2011, the company offers a range of products designed for interventional medicine, including microcatheters, guidewires, and various vascular access devices. Notably, Ricoton's equipment features a comprehensive set that includes a micro guide wire, micro catheter, support catheter, thrombectomy stent, balloon guide catheter, and intracranial balloon dilatation catheter. This innovative lineup provides a one-stop thrombectomy solution aimed at enhancing the treatment and prevention of cerebrovascular conditions.
Jiangsu Jing Chuang Advanced Electronic Technology
Series B in 2023
Jiangsu Jing Chuang Advanced Electronic Technology focuses on the research and development of equipment for the semiconductor manufacturing sector. The company specializes in high-precision grinding machines and offers a range of products, including automatic laser saws, dicing saws, and wafer cleaning equipment. By providing comprehensive solutions for semiconductor material dicing applications, Jing Chuang Advanced aims to support the growing demands of the semiconductor industry.
Xinchuangyuan Semiconductor
Series A in 2023
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment.
Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.
Hochuen Medical
Series B in 2023
Hochuen Medical USA Corp., established in 2015 by industry veterans Dr. Robin Liu and Eric Zeng, specializes in the design, development, and mass production of medical devices and consumables as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM). The company focuses on In Vitro Diagnostics (IVD), wearable medical technology, and microfluidic devices, with a portfolio including COVID-19 testing kits and various medical disposables. Hochuen Medical operates as a Contract Development and Manufacturing Organization (CDMO), producing high-quality products such as microfluidic biochips, IVD disposable consumables, point-of-care testing kits, and gene sequencing chips for clients worldwide. The company is committed to quality, holding FDA registration and ISO certifications, and aims to contribute innovative solutions to the healthcare industry through continuous research and development.
Bio-Link is a drug development company founded in 2001 and headquartered in Shanghai, China. It specializes in providing bioprocessing solutions for the life science industry, including the development and manufacturing of key process equipment and consumables. Bio-Link's offerings include technologies for vaccines, antibody drugs, cell therapy, gene therapy, and various biologics. The company focuses on upstream cell culture, disposable dispensing reservoirs, and downstream processes such as chromatography and ultrafiltration. By delivering innovative products and services, Bio-Link aims to enhance the efficiency, safety, and competitiveness of the biopharmaceutical supply chain. Additionally, the company explores wearable technology solutions for elderly care, further diversifying its portfolio.
Focallure
Series B in 2022
Focallure is a cosmetic company headquartered in Guangzhou, China, specializing in the development and manufacturing of makeup products. The company emphasizes base makeup and a variety of cosmetics, utilizing big data analysis to enhance its operations. By analyzing consumer product preferences and social content trends, Focallure aims to provide users with an innovative and refreshing makeup experience.
Prismlab China
Series C in 2022
Prismlab China Ltd. is a high-tech enterprise established in 2005, specializing in the development, production, and sales of high-speed light-curing 3D printers. The company integrates optical, mechanical, and electrical technology with computer software and hardware, alongside photopolymer materials. Prismlab's primary focus is on research and development, manufacturing, and marketing of rapid prototyping machines utilizing stereolithography (SLA) technology. Its innovative products are recognized for their quality and performance, reaching customers in over 50 countries and regions, and have garnered critical acclaim from users around the globe.
MeetFuture
Series B in 2022
MeetFuture China is a technology-driven company specializing in automated transmission systems for the pan-semiconductor industry. Established in 2016, it offers innovative automation solutions aimed at enhancing industrial upgrading and development. The company leverages control theory, computer technology, and information systems to deliver effective industrial detection, control, optimization, dispatch, and management solutions. By implementing these advanced technologies, MeetFuture enables its clients to reduce operational costs and optimize production parameters, thereby improving overall efficiency and productivity in the semiconductor sector.
Cencorp Automation
Series A in 2022
Cencorp Automation is a provider of process automation solutions focused on the electronics industry. The company offers a diverse range of equipment solutions, including depaneling, odd-form assembly, test handling, laser marking, laser welding, and final assembly. Cencorp aims to enhance the productivity and quality of its clients' production processes through innovative automation platforms. The company's clientele includes prominent players in sectors such as car electronics, telecommunications, and industrial electronics, highlighting its commitment to delivering effective and affordable automation solutions.
Xinchuangyuan Semiconductor
Series A in 2021
Xinchuangyuan Semiconductor is a manufacturing company of electronic equipment.
Xinchuangyuan Semiconductor was founded in 2021 and was headquartered in Wuhan, China.
Platelet BioGenesis
Series B in 2021
Platelet BioGenesis, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2014. It specializes in the production of donor-independent human platelets derived from pluripotent stem cells for clinical applications. The company has developed a microfluidic bioreactor that enables the generation of functional platelets at commercial scale from human stem cell cultures. These bioreactor-produced platelets are distributed to hospitals and blood banks, providing essential therapeutic resources to patients globally. Through its innovative approach, Platelet BioGenesis is contributing to advancements in biotechnology and the field of transfusion medicine.
Okeanos Technology
Series B in 2021
Okeanos Technology specializes in the custom synthesis and production of specialized chemical biological reagents and pharmaceutical intermediates tailored for the life sciences sector. The company offers a diverse range of products, including modified nucleotides, unnatural amino acids, heterocycles, as well as fluorescent and labeling reagents. Okeanos serves prominent pharmaceutical companies, delivering high-quality chemical compounds and intermediates that support various applications in research and development. Renowned for its commitment to quality and innovation, Okeanos has established a strong reputation among its clients in the pharmaceutical industry.
Hochuen Medical
Series A in 2021
Hochuen Medical USA Corp., established in 2015 by industry veterans Dr. Robin Liu and Eric Zeng, specializes in the design, development, and mass production of medical devices and consumables as an Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM). The company focuses on In Vitro Diagnostics (IVD), wearable medical technology, and microfluidic devices, with a portfolio including COVID-19 testing kits and various medical disposables. Hochuen Medical operates as a Contract Development and Manufacturing Organization (CDMO), producing high-quality products such as microfluidic biochips, IVD disposable consumables, point-of-care testing kits, and gene sequencing chips for clients worldwide. The company is committed to quality, holding FDA registration and ISO certifications, and aims to contribute innovative solutions to the healthcare industry through continuous research and development.
Render is a Chinese manufacturer of high-tech medical products and solutions. Render is a Shenzhen-based company that was founded in 2010.
MeetFuture
Series A in 2021
MeetFuture China is a technology-driven company specializing in automated transmission systems for the pan-semiconductor industry. Established in 2016, it offers innovative automation solutions aimed at enhancing industrial upgrading and development. The company leverages control theory, computer technology, and information systems to deliver effective industrial detection, control, optimization, dispatch, and management solutions. By implementing these advanced technologies, MeetFuture enables its clients to reduce operational costs and optimize production parameters, thereby improving overall efficiency and productivity in the semiconductor sector.
Just Medical
Series B in 2021
Just Medical is a developer and manufacturer of artificial orthopedic implant devices and systems, specializing in products such as artificial hip and knee joints, internal fixation products, and orthopedic surgical instruments. The company is dedicated to enhancing surgical efficiency and improving the quality of orthopedic treatment through advanced technology research and development. Just Medical focuses on creating safe and effective medical products and services, continually refining its product system to address the needs of healthcare providers and alleviate patient pain. Its commitment to high-speed development and excellence positions it as a key player in the orthopedic medical device industry.
Delta Medical
Series E in 2021
Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.
Saints & Sages
Series A in 2021
Saints & Sages Medical specializes in the development and production of minimally invasive surgical medical devices. The company offers a range of energy devices that are utilized across various medical fields, including hepatobiliary, gynecology, urology, thoracic surgery, thyroid and breast surgery, and gastrointestinal surgery. With a commitment to addressing clinical needs, Saints & Sages focuses on innovation in surgical technology. They leverage a dedicated research and development team and extensive clinical experience to create devices that enhance the precision and efficiency of surgical procedures, ultimately aiming to improve patient outcomes globally.
MoreWis is a platform service provider focused on facilitating the digital transformation of the manufacturing industry. The company develops the MC MorewisCloud industrial Internet platform, which supports collaborative development and application ecology for industrial software. MoreWis offers customized solutions and industrial application software, including Manufacturing Operations Management (MOM), Manufacturing Execution Systems (MES), and Warehouse Management Systems (WMS). Its cloud-based manufacturing execution system is utilized across various sectors, including surface mounted technology, electronic assembly, green energy battery solutions, and smart factories. By enabling clients to integrate data analytics and real-time monitoring into their production processes, MoreWis supports the intelligent transformation of industrial enterprises.
MicroTech Medical
Series D in 2020
MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.
Compart Systems
Venture Round in 2020
Founded in Singapore in 2016, Compart Systems is a global supplier of precision-engineered metal components. It specializes in manufacturing and distributing high-precision flow control products such as valves, regulators, filters, transducers, and mass flow controllers, serving the semiconductor, industrial, and medical industries.
Delta Medical
Series D in 2020
Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.
52toys
Secondary Market in 2020
52toys is an animation and intellectual property operator based in Beijing that develops its own IP and licenses IP for toy products, delivering entertainment to consumers of all ages and enabling exploration of new and familiar designs.
MicroTech Medical
Venture Round in 2020
MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.
Platelet BioGenesis
Series A in 2019
Platelet BioGenesis, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2014. It specializes in the production of donor-independent human platelets derived from pluripotent stem cells for clinical applications. The company has developed a microfluidic bioreactor that enables the generation of functional platelets at commercial scale from human stem cell cultures. These bioreactor-produced platelets are distributed to hospitals and blood banks, providing essential therapeutic resources to patients globally. Through its innovative approach, Platelet BioGenesis is contributing to advancements in biotechnology and the field of transfusion medicine.
Shenzhen Tisenc Medical Devices Co., Ltd., established in 2015, is a Sino-foreign joint venture based in Shenzhen, Guangdong. The company specializes in the development, manufacturing, and global sales of chemiluminescence immunology systems and advanced diagnostic solutions. Tisenc focuses on creating automatic chemiluminescent analyzers and supporting diagnostic reagents, which are essential in the field of medical diagnostics and point-of-care testing. With over 16,000 square meters dedicated to research and development labs, a GMP factory, and an instrument manufacturing facility, Tisenc maintains full intellectual property rights for its products and technologies, ensuring independence in its research and production processes.
Delta Medical
Series C in 2019
Beijing Delta Medical Co., Ltd. specializes in the design and manufacture of orthopedic surgical instruments and rehabilitation products. The company offers a range of products, including shoulder arthroscopic instruments, various types of suture anchors, instruments for anterior and posterior cruciate ligament reconstruction, interference screws, and shaver systems. In addition to its surgical instruments, Delta Medical provides sports rehabilitation services. The company is headquartered in Beijing, China, and focuses on delivering innovative solutions in sports medicine.
APT Medical
Venture Round in 2019
APT Medical Inc. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacture, and sale of minimally invasive interventional medical devices for cardiovascular and cerebrovascular diseases. Founded in 2002, the company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, and vascular intervention products, which encompass diagnostic and treatment solutions as well as accessory items. APT Medical also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services for catheter and metal products. The company operates production facilities in Shenzhen and Hunan, and its products are distributed in various regions, including Europe and Southeast Asia.
Bondent Technology Co., Ltd., headquartered in Shanghai, China, specializes in supplying dental equipment and materials. It offers a comprehensive range of services, including technical training, operational and management consulting, decoration design, and financial solutions. Bondent's core business involves the design, development, manufacturing, and sales of oral medical equipment, creating a full ecosystem for the dental and oral health industry.
Mech-Mind Robotics
Series A in 2019
Mech-Mind Robotics Technologies is a prominent manufacturer based in Beijing, China, specializing in hardware and software solutions for the logistics industry. Founded in 2016, the company produces advanced smart cameras, including the Mech-Eye series, which are designed for tasks such as object recognition, depalletizing, assembly, sorting, and locating. Mech-Mind also develops AI-powered software that enables robotic cameras to identify and process objects of various shapes and sizes. With over 10,000 cameras deployed across more than 50 countries, Mech-Mind Robotics supports partners and system integrators in tackling complex automation challenges, including bin picking and assembly tasks, thereby enhancing operational efficiency in the e-commerce and logistics sectors. The company further extends its reach with an office in Munich, Germany, and a sales office in Shanghai, China.
Bomming Vision
Series A in 2019
Zhuhai Bomming Vision Technology is a high-tech company based in Zhuhai, China, specializing in the development and application of machine vision technology. With a core team that possesses over 15 years of experience in image acquisition, recognition, and algorithm development, Bomming Vision focuses on creating advanced vision processing software systems and high-precision optical inspection equipment. These products cater to various industries and are primarily aimed at enhancing quality assurance processes through accurate and efficient optical measurement solutions.
52toys is an animation and intellectual property operator based in Beijing that develops its own IP and licenses IP for toy products, delivering entertainment to consumers of all ages and enabling exploration of new and familiar designs.
Emergen is a developer and manufacturer specializing in intelligent robotics and manufacturing solutions, founded by Dr. Gan Middle School, a distinguished expert in the national "Thousand Talents Program." The company focuses on creating high-performance robotic products with independent intellectual property rights, aiming to disrupt foreign monopolies in key robotic components. Emergen has developed two core technologies: a distributed intelligent robot controller and a group intelligence network controller. These innovations are integral to the construction of smart factories, enabling closed-loop control of process data, traceability of quality information, and comprehensive management of intelligent logistics. The company is committed to advancing the field of intelligent manufacturing, providing solutions that enhance efficiency and productivity across various industrial applications.
ACEA Biosciences
Venture Round in 2019
ACEA Biosciences, Inc., established in 2002 and headquartered in San Diego, California, specializes in developing and commercializing microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. The company's flagship product, the x-CELLigence System, offers real-time, label-free cell analysis, serving diverse applications such as cell proliferation, cytotoxicity testing, and receptor function monitoring. ACEA's products cater to science research and drug discovery markets, with over 800 customers worldwide and numerous peer-reviewed publications. The company operates a state-of-the-art manufacturing facility in Hangzhou, China, and serves its global customer base as a subsidiary of Agilent Technologies, Inc.
NASN Automotive Electronics
Series B in 2019
NASN Automotive Electronics Co., Ltd. is a manufacturer based in Shanghai, China, specializing in electronic chassis control products and autonomous driving technologies for the automotive market. The company focuses on developing advanced systems such as the NBooster intelligent brake system, brushless electric steering EPS controller, and wire control systems. NASN is dedicated to integrating research and development with production and sales, aiming to enhance vehicle safety and intelligence. By providing innovative solutions, NASN Automotive Electronics supports the growing demand for advanced driver assistance systems and contributes to the evolution of autonomous driving in China.
MicroTech Medical
Series C in 2018
MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.
APT Medical
Series C in 2018
APT Medical Inc. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacture, and sale of minimally invasive interventional medical devices for cardiovascular and cerebrovascular diseases. Founded in 2002, the company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, and vascular intervention products, which encompass diagnostic and treatment solutions as well as accessory items. APT Medical also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services for catheter and metal products. The company operates production facilities in Shenzhen and Hunan, and its products are distributed in various regions, including Europe and Southeast Asia.
NASN Automotive Electronics
Series A in 2018
NASN Automotive Electronics Co., Ltd. is a manufacturer based in Shanghai, China, specializing in electronic chassis control products and autonomous driving technologies for the automotive market. The company focuses on developing advanced systems such as the NBooster intelligent brake system, brushless electric steering EPS controller, and wire control systems. NASN is dedicated to integrating research and development with production and sales, aiming to enhance vehicle safety and intelligence. By providing innovative solutions, NASN Automotive Electronics supports the growing demand for advanced driver assistance systems and contributes to the evolution of autonomous driving in China.
DK Medtech
Series B in 2018
DK Medtech is a medical technology company based in Suzhou, China, specializing in the development and production of balloon catheter medical devices. Founded in 2015, the company has positioned itself as a leader in the medical device industry, focusing on innovative solutions to address complex healthcare challenges. Through its commitment to excellence, DK Medtech aims to improve patient outcomes and enhance the quality of healthcare.
APT Medical
Series B in 2018
APT Medical Inc. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacture, and sale of minimally invasive interventional medical devices for cardiovascular and cerebrovascular diseases. Founded in 2002, the company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, and vascular intervention products, which encompass diagnostic and treatment solutions as well as accessory items. APT Medical also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services for catheter and metal products. The company operates production facilities in Shenzhen and Hunan, and its products are distributed in various regions, including Europe and Southeast Asia.
Shenzhen Tisenc Medical Devices Co., Ltd., established in 2015, is a Sino-foreign joint venture based in Shenzhen, Guangdong. The company specializes in the development, manufacturing, and global sales of chemiluminescence immunology systems and advanced diagnostic solutions. Tisenc focuses on creating automatic chemiluminescent analyzers and supporting diagnostic reagents, which are essential in the field of medical diagnostics and point-of-care testing. With over 16,000 square meters dedicated to research and development labs, a GMP factory, and an instrument manufacturing facility, Tisenc maintains full intellectual property rights for its products and technologies, ensuring independence in its research and production processes.
Wuxi Vision Pro
Series B in 2018
Wuxi Vision Pro Ltd. is a prominent manufacturer of ophthalmic medical devices, specializing in the research, development, production, and marketing of intraocular lenses and related products. Established in 2010 and headquartered in Wuxi, China, with an additional location in Irvine, California, the company is dedicated to advancing eye care worldwide. Its portfolio features high refractive index hydrophobic acrylic biocompatible materials, which are crucial for the production of sophisticated ophthalmic devices. Wuxi Vision Pro focuses on developing high-quality lenses aimed at treating various ophthalmic conditions, including cataracts, glaucoma, and retinal diseases. The company prides itself on maintaining rigorous standards in research, development, and quality control to ensure the efficacy and reliability of its products for the global ophthalmic industry.
Bondent Technology Co., Ltd., headquartered in Shanghai, China, specializes in supplying dental equipment and materials. It offers a comprehensive range of services, including technical training, operational and management consulting, decoration design, and financial solutions. Bondent's core business involves the design, development, manufacturing, and sales of oral medical equipment, creating a full ecosystem for the dental and oral health industry.
52toys is an animation and intellectual property operator based in Beijing that develops its own IP and licenses IP for toy products, delivering entertainment to consumers of all ages and enabling exploration of new and familiar designs.
ACEA Biosciences
Series E in 2018
ACEA Biosciences, Inc., established in 2002 and headquartered in San Diego, California, specializes in developing and commercializing microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. The company's flagship product, the x-CELLigence System, offers real-time, label-free cell analysis, serving diverse applications such as cell proliferation, cytotoxicity testing, and receptor function monitoring. ACEA's products cater to science research and drug discovery markets, with over 800 customers worldwide and numerous peer-reviewed publications. The company operates a state-of-the-art manufacturing facility in Hangzhou, China, and serves its global customer base as a subsidiary of Agilent Technologies, Inc.
Bomming Vision
Series A in 2018
Zhuhai Bomming Vision Technology is a high-tech company based in Zhuhai, China, specializing in the development and application of machine vision technology. With a core team that possesses over 15 years of experience in image acquisition, recognition, and algorithm development, Bomming Vision focuses on creating advanced vision processing software systems and high-precision optical inspection equipment. These products cater to various industries and are primarily aimed at enhancing quality assurance processes through accurate and efficient optical measurement solutions.
SinoVision Technologies
Series B in 2017
Sinovision,one of the most professional manufacturers in security industry in China, Provides comprehensive services that cover R&D, producing, marketing and after sales service. Our full range of various products including HD CCTV(AHD/TVI/CVI) Camera, Speed Dome Camera, DVR,IP Network Camera,NVR, and Smart Home Products' demands in both domestic and overseas market, and built in an excellent reputation in the world.
They have a specialized R&D team and the high quality terminal production equipment. Their R&D team are constantly devoted to improve existing products and develop new products in order to provide our global customers with top-quality products, they accumulated a wealth of experience in the CCTV and IT industries after these years’ development.
VR Medical
Series B in 2017
VR Medical, established in 2009, is a US-based company that specializes in providing comprehensive manufacturing solutions for medical device companies and distributors. The company focuses on offering a single-sourced solution for new product development, outsourcing, contract manufacturing, and secure product distribution within China. VR Medical's unique capabilities include the development and low-cost manufacturing of disposable products and electronic devices, catering to private labels, OEMs, and distributors globally. Their medical devices are designed to support various medical markets, including respiratory care, critical care, blood purification, and advanced wound care.
Kintep Environmental
Series B in 2017
Kintep Environmental is a manufacturer specializing in sludge treatment equipment and environmental services aimed at promoting sustainability in China. The company is dedicated to research and development to enhance its product offerings, ensuring they remain at the forefront of environmental technology. Kintep's products cater to a diverse range of industries, including papermaking, printing and dyeing, and food and beverage, providing clients with effective solutions for environmentally responsible waste disposal. Through its innovative approach, Kintep Environmental supports efforts to transform communities into more sustainable environments.
SceneRay Co. Ltd, based in Singapore Industrial Park in Suzhou, China, is a medical device company specializing in the design, development, and distribution of neuromodulation devices. The company focuses on creating advanced medical products, including a dual-channel implantable pulse generator kit for deep brain stimulation. This technology is designed to provide effective treatments for patients suffering from brain damage through electric stimulation. SceneRay's core team comprises experts with extensive experience in neuromodulation device development, manufacturing, and marketing, both in China and internationally. The company holds numerous patents and is committed to exploring innovative solutions in the field of neuromodulation, aiming to deliver high-quality and effective treatments to improve patient outcomes.
Zai Lab is a biopharmaceutical company dedicated to discovering and developing transformative medicines for cancer, autoimmune, and infectious diseases. Founded in Shanghai in 2014, the company focuses on bringing innovative therapies to patients worldwide. Zai Lab's pipeline includes proprietary drug candidates such as Niraparib, Optune, Ripretinib, and Margetuximab, among others. The company collaborates with global biopharma leaders to expand its pipeline and foster innovation in China.
Platelet BioGenesis
Series A in 2017
Platelet BioGenesis, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2014. It specializes in the production of donor-independent human platelets derived from pluripotent stem cells for clinical applications. The company has developed a microfluidic bioreactor that enables the generation of functional platelets at commercial scale from human stem cell cultures. These bioreactor-produced platelets are distributed to hospitals and blood banks, providing essential therapeutic resources to patients globally. Through its innovative approach, Platelet BioGenesis is contributing to advancements in biotechnology and the field of transfusion medicine.
SinocellTech
Series A in 2017
Sinocelltech is a biotechnology company focused on the development and industrialization of biopharmaceutical products, including monoclonal antibodies, recombinant proteins, and vaccines. The company has established advanced technology platforms that encompass protein expression vectors, cell line development, and serum-free medium development. It specializes in stoichiometrically controlled fed-batch cell culture, process scale-up, and protein purification. Sinocelltech's capabilities include the development of stable Chinese Hamster Ovary (CHO) cell lines, cell banking, and certification, as well as optimization and large-scale production processes. The company aims to provide life-saving biological medicines to a broader population by continuously improving its manufacturing technologies to reduce production and development costs.
CanSinoBIO
Series E in 2017
CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.
Bomming Vision
Series A in 2017
Zhuhai Bomming Vision Technology is a high-tech company based in Zhuhai, China, specializing in the development and application of machine vision technology. With a core team that possesses over 15 years of experience in image acquisition, recognition, and algorithm development, Bomming Vision focuses on creating advanced vision processing software systems and high-precision optical inspection equipment. These products cater to various industries and are primarily aimed at enhancing quality assurance processes through accurate and efficient optical measurement solutions.
Anssure Pharma
Series A in 2017
Anssure Pharma specializes in the development and production of transdermal patches aimed at treating various medical conditions. The company focuses on pharmaceuticals for orthopedics, gynecology, pediatrics, and women's health. By providing innovative medical technology, Anssure Pharma enables healthcare providers to effectively treat patients suffering from these specific diseases, ultimately enhancing patient care and improving quality of life.
Bondent Technology Co., Ltd., headquartered in Shanghai, China, specializes in supplying dental equipment and materials. It offers a comprehensive range of services, including technical training, operational and management consulting, decoration design, and financial solutions. Bondent's core business involves the design, development, manufacturing, and sales of oral medical equipment, creating a full ecosystem for the dental and oral health industry.
MicroTech Medical
Series B in 2017
MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.
MicroTech Medical
Series B in 2016
MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.
Finern Automation is a service provider of intelligent plant, committed to providing comprehensive solutions for the industry of advanced manufacture. Since founded in 2011, the company has established 3 research and manufacturing centers in Shanghai, Shenzhen and Wuhan in China, as well as agencies in Hong Kong, US and France, to provide customers with technical support and business consulting. Finern Automation branches out its core business into the fields of consumer electronics, vehicle electronics and new energy.
Cencorp Automation
Series A in 2016
Cencorp Automation is a provider of process automation solutions focused on the electronics industry. The company offers a diverse range of equipment solutions, including depaneling, odd-form assembly, test handling, laser marking, laser welding, and final assembly. Cencorp aims to enhance the productivity and quality of its clients' production processes through innovative automation platforms. The company's clientele includes prominent players in sectors such as car electronics, telecommunications, and industrial electronics, highlighting its commitment to delivering effective and affordable automation solutions.
Bondent Technology Co., Ltd., headquartered in Shanghai, China, specializes in supplying dental equipment and materials. It offers a comprehensive range of services, including technical training, operational and management consulting, decoration design, and financial solutions. Bondent's core business involves the design, development, manufacturing, and sales of oral medical equipment, creating a full ecosystem for the dental and oral health industry.
APT Medical
Series A in 2016
APT Medical Inc. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacture, and sale of minimally invasive interventional medical devices for cardiovascular and cerebrovascular diseases. Founded in 2002, the company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, and vascular intervention products, which encompass diagnostic and treatment solutions as well as accessory items. APT Medical also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services for catheter and metal products. The company operates production facilities in Shenzhen and Hunan, and its products are distributed in various regions, including Europe and Southeast Asia.
VINNO Technology
Series C in 2016
VINNO Technology, founded in 2010 in Suzhou Industrial Park, specializes in the development and manufacture of high-end color Doppler ultrasound diagnostic systems. With a focus on innovation, the company produces a range of ultrasound equipment, including consoles and portable imaging tools, aimed at enhancing diagnostic processes in hospitals and clinics. By providing accessible medical solutions, VINNO enables healthcare professionals to deliver more accurate and efficient diagnoses and treatments for patients. The company is based in China and actively seeks partnerships globally to expand its reach and bring advanced medical technology to a wider audience.
CanSinoBIO
Venture Round in 2016
CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.
AirQuality
Series B in 2016
AirQuality is a manufacturer and innovator in air-cleaning technologies, dedicated to providing clean air solutions globally. The company specializes in central air purification systems tailored for the Chinese market, offering a comprehensive platform that includes design, installation, and maintenance services. Its environmentally friendly products cater to a variety of settings, such as homes, offices, hotels, hospitals, schools, and public buildings, ensuring that customers can enjoy fresh and healthy air in their environments. AirQuality emphasizes values of gratitude, excellence, and innovation in its mission to improve air quality for all.
ACEA Biosciences
Series E in 2016
ACEA Biosciences, Inc., established in 2002 and headquartered in San Diego, California, specializes in developing and commercializing microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. The company's flagship product, the x-CELLigence System, offers real-time, label-free cell analysis, serving diverse applications such as cell proliferation, cytotoxicity testing, and receptor function monitoring. ACEA's products cater to science research and drug discovery markets, with over 800 customers worldwide and numerous peer-reviewed publications. The company operates a state-of-the-art manufacturing facility in Hangzhou, China, and serves its global customer base as a subsidiary of Agilent Technologies, Inc.
SMTP Technology
Series A in 2016
SMTP Technology Co., Ltd. specializes in the research, development, and manufacturing of orthopedic medical instruments, with a particular emphasis on ultrasonic osteotomy surgery instruments. Established in 2011 and headquartered in Zhangjiagang, China, the company aims to enhance surgical outcomes through innovative medical devices. SMTP Technology markets its products through a network of medical product distributors, striving to offer improved solutions for both surgeons and patients in the orthopedic field.
MicroTech Medical
Series A in 2016
MicroTech Medical, founded in January 2011 in Hangzhou Future Technical City, is a company focused on the research, development, and manufacturing of innovative and affordable medical devices for diabetes care. The firm specializes in creating both treatment and monitoring devices aimed at improving diabetes management, primarily serving the Chinese market while also reaching international customers. With significant backing from Eli Lilly and Company, MicroTech Medical is dedicated to enhancing the quality of life for individuals living with diabetes through advanced technology solutions.
Zai Lab is a biopharmaceutical company dedicated to discovering and developing transformative medicines for cancer, autoimmune, and infectious diseases. Founded in Shanghai in 2014, the company focuses on bringing innovative therapies to patients worldwide. Zai Lab's pipeline includes proprietary drug candidates such as Niraparib, Optune, Ripretinib, and Margetuximab, among others. The company collaborates with global biopharma leaders to expand its pipeline and foster innovation in China.
Nurotron Biotechnology
Series C in 2015
Zhejiang Nurotron Biotechnology Co., Ltd. is a high-tech enterprise based in Hangzhou, China, specializing in the development and manufacturing of neuroelectronic products. The company primarily focuses on cochlear implant systems, including cochlear speech processors and multi-channel cochlear implants designed for individuals with severe to profound hearing loss. Nurotron also offers accessories and online consulting services to support users of their products. Established in 2006, the company has a research and development center in California, USA, where it works on advancing technologies such as multipath manual electrical cochlea systems and auditory brainstem implant equipment. Through its innovative products, Nurotron aims to help individuals regain their hearing ability in various environments.
ACEA Biosciences
Venture Round in 2015
ACEA Biosciences, Inc., established in 2002 and headquartered in San Diego, California, specializes in developing and commercializing microelectronic sensor systems for cell-based assays, drug discovery, and diagnostics. The company's flagship product, the x-CELLigence System, offers real-time, label-free cell analysis, serving diverse applications such as cell proliferation, cytotoxicity testing, and receptor function monitoring. ACEA's products cater to science research and drug discovery markets, with over 800 customers worldwide and numerous peer-reviewed publications. The company operates a state-of-the-art manufacturing facility in Hangzhou, China, and serves its global customer base as a subsidiary of Agilent Technologies, Inc.
CanSinoBIO
Series C in 2015
CanSino Biologics Inc. is a biotechnology company based in Tianjin, China, focused on the research, development, manufacturing, and commercialization of vaccines. The company is actively developing a range of vaccines, including those for Ebola, meningitis, pertussis, and pneumococcal diseases, with multiple candidates currently in various phases of clinical trials. Notable products under development include the recombinant coronavirus vaccine Ad5-nCov, as well as several preclinical stage vaccines targeting adenovirus, Zika virus, meningitis, shingles, and polio. CanSino collaborates with the National Research Council of Canada to advance COVID-19 vaccine initiatives and has a co-development agreement with Precision NanoSystems to create an mRNA lipid nanoparticle vaccine against COVID-19. Founded in 2009, CanSino aims to meet the unmet medical needs in China and other emerging markets by providing high-quality vaccines at affordable prices.
Wuxi Vision Pro
Series A in 2015
Wuxi Vision Pro Ltd. is a prominent manufacturer of ophthalmic medical devices, specializing in the research, development, production, and marketing of intraocular lenses and related products. Established in 2010 and headquartered in Wuxi, China, with an additional location in Irvine, California, the company is dedicated to advancing eye care worldwide. Its portfolio features high refractive index hydrophobic acrylic biocompatible materials, which are crucial for the production of sophisticated ophthalmic devices. Wuxi Vision Pro focuses on developing high-quality lenses aimed at treating various ophthalmic conditions, including cataracts, glaucoma, and retinal diseases. The company prides itself on maintaining rigorous standards in research, development, and quality control to ensure the efficacy and reliability of its products for the global ophthalmic industry.
SMTP Technology
Series A in 2015
SMTP Technology Co., Ltd. specializes in the research, development, and manufacturing of orthopedic medical instruments, with a particular emphasis on ultrasonic osteotomy surgery instruments. Established in 2011 and headquartered in Zhangjiagang, China, the company aims to enhance surgical outcomes through innovative medical devices. SMTP Technology markets its products through a network of medical product distributors, striving to offer improved solutions for both surgeons and patients in the orthopedic field.
Zai Lab is a biopharmaceutical company dedicated to discovering and developing transformative medicines for cancer, autoimmune, and infectious diseases. Founded in Shanghai in 2014, the company focuses on bringing innovative therapies to patients worldwide. Zai Lab's pipeline includes proprietary drug candidates such as Niraparib, Optune, Ripretinib, and Margetuximab, among others. The company collaborates with global biopharma leaders to expand its pipeline and foster innovation in China.
Mitralign
Series E in 2015
Mitralign is a privately held medical device company based in a suburb of Boston, Massachusetts. It specializes in developing catheter-based technologies for the percutaneous treatment of functional mitral regurgitation, a global and life-threatening cardiac condition. The company's innovative Mitralign system mimics surgical annuloplasty by delivering a series of implants directly into the mitral annulus via a catheter, reducing its size and improving valve function. Mitralign is backed by top-tier venture capitalists and has strategic investments from major cardiovascular device companies.
Nurotron Biotechnology
Series C in 2014
Zhejiang Nurotron Biotechnology Co., Ltd. is a high-tech enterprise based in Hangzhou, China, specializing in the development and manufacturing of neuroelectronic products. The company primarily focuses on cochlear implant systems, including cochlear speech processors and multi-channel cochlear implants designed for individuals with severe to profound hearing loss. Nurotron also offers accessories and online consulting services to support users of their products. Established in 2006, the company has a research and development center in California, USA, where it works on advancing technologies such as multipath manual electrical cochlea systems and auditory brainstem implant equipment. Through its innovative products, Nurotron aims to help individuals regain their hearing ability in various environments.
Zai Lab is a biopharmaceutical company dedicated to discovering and developing transformative medicines for cancer, autoimmune, and infectious diseases. Founded in Shanghai in 2014, the company focuses on bringing innovative therapies to patients worldwide. Zai Lab's pipeline includes proprietary drug candidates such as Niraparib, Optune, Ripretinib, and Margetuximab, among others. The company collaborates with global biopharma leaders to expand its pipeline and foster innovation in China.
Intelligent Automation
Series B in 2014
Intelligent Automation was founded in 2006 in Zhuhai. In 2015 they became the famous list firm CYG’s subsidiary and stock code is 600525.SH.
They have been focusing on the research and development of high-end automatic test equipment and assembly equipment. Hitherto they have provided their high quality solution on the industries of consumer electronic, automotive, medical, new energy and LED lighting, industry.
VINNO Technology
Series B in 2014
VINNO Technology, founded in 2010 in Suzhou Industrial Park, specializes in the development and manufacture of high-end color Doppler ultrasound diagnostic systems. With a focus on innovation, the company produces a range of ultrasound equipment, including consoles and portable imaging tools, aimed at enhancing diagnostic processes in hospitals and clinics. By providing accessible medical solutions, VINNO enables healthcare professionals to deliver more accurate and efficient diagnoses and treatments for patients. The company is based in China and actively seeks partnerships globally to expand its reach and bring advanced medical technology to a wider audience.
APT Medical
Series A in 2014
APT Medical Inc. is a high-tech enterprise based in Shenzhen, China, specializing in the research, development, manufacture, and sale of minimally invasive interventional medical devices for cardiovascular and cerebrovascular diseases. Founded in 2002, the company offers a range of products, including electrophysiological catheter delivery systems, radiofrequency ablation and mapping catheters, and vascular intervention products, which encompass diagnostic and treatment solutions as well as accessory items. APT Medical also provides original equipment manufacturing (OEM) and original design manufacturing (ODM) services for catheter and metal products. The company operates production facilities in Shenzhen and Hunan, and its products are distributed in various regions, including Europe and Southeast Asia.
Shanghai Sanyou Medical
Series A in 2014
Shanghai Sanyou Medical Co., Ltd., based in Shanghai, specializes in the research, development, manufacturing, and sales of orthopedic implants in China. The company offers a range of products under the Tytus and Sanyou brands, including spinal implants like anterior cervical plates, posterior thoracolumbar systems, and minimally invasive products, as well as trauma implants for shoulders, elbows, hips, knees, and wrists. Established in 2010, the company is committed to independent innovation and has a senior international management team.